Loading...
•
Oct 04, 2020
Revvity Q3 2020 Earnings Report
PerkinElmer reported revenue of $964.0 million with 36% reported growth and 34% organic growth. GAAP EPS from continuing operations was $1.57 and adjusted EPS was $2.09.
Key Takeaways
PerkinElmer reported strong financial results for the third quarter of 2020, with significant revenue growth driven by the Diagnostics segment. The company's GAAP EPS and adjusted EPS also showed substantial increases compared to the same period last year, reflecting improved profitability.
Revenue reached $964.0 million, demonstrating 36% reported growth and 34% organic growth.
GAAP EPS from continuing operations was $1.57, up from $0.53 in Q3 2019.
Adjusted EPS was $2.09, compared to $1.06 in Q3 2019.
Operating income from continuing operations was $248.0 million, significantly higher than $78.7 million in the prior year.
Revvity
Revvity
Revvity Revenue by Segment
Revenue by Segment
Diagnostics Revenue
CapyFin.com Forward Guidance
The Company forecasts for the fourth quarter of 2020, GAAP revenue in the range of $1.12 billion to $1.23 billion, GAAP earnings per share from continuing operations of $2.27 to $2.67 and, on a non-GAAP basis, adjusted earnings per share of $2.60 to $3.00.